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Introduction
mRNA turnover is a key factor in the regulation of eukaryotic 
gene expression, which, in parallel to transcriptional activa-
tion/repression, allows cells to rapidly adjust their levels of spe-
cific transcripts in response to environmental stress conditions. 
Information on how different stress conditions impact on the 
post-transcriptional fate of stress-responsive mRNAs, however is 
still quite limited. Studies in Saccharomyces cerevisiae for instance 
suggest that heat shock favors the stabilization of heat-shock 
inducible mRNAs, while pre-existing mRNAs may suffer from 
accelerated degradation via the 5'-3' mRNA decay pathway or be 
shifted from polysomes toward a repressing mRNA state within 
P bodies.1-3 Similarly, nutrient limitation or inactivation of the 
nutrient-regulated target of rapamycin complex 1 (TORC1) 
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broadly stimulates 5'-3' mRNA decay,4 while specifically endors-
ing the protection of newly expressed mRNAs of genes (e.g., 
HSP26 ) that are controlled by the stress-responsive and/or nutri-
ent-regulated transcription factors Msn2, Msn4 and Gis1.5
The limited amount of information on mRNA half-lives of 
stress-responsive genes is primarily due to the fact that most of 
the currently available methods to assess mRNA half-lives suf-
fer from caveats that specifically affect stress-responsive mRNAs. 
For instance, assays that allow determination of mRNA half-
lives are traditionally based on inhibition of general transcription 
using either a temperature-sensitive allele of the catalytic subunit 
of RNA polymerase II (RNA Pol II; i.e., rpb1-1),6 or a variety of 
transcription inhibitors (e.g., thiolutin and 1,10-phenanthroline).7 
However, both interventions per se, namely temperature-shift 
(when using rpb1-1 strains) and thiolutin/1,10-phenanthroline 
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transcriptome analysis (DTA), which combines 
metabolic mRNA labeling with dynamic kinetic 
modeling, is applicable on a genome-wide level 
and may currently be best suited to estimate 
mRNA half-lives under stress conditions.13,16 
A theoretical concern of this method, which is 
technically challenging,15 may be the fact that it 
is built on the assumption that mRNA synthe-
sis and decay rates remain constant during the 
labeling time.
To specifically study the mRNA half-life of 
individual stress-responsive mRNAs, we devel-
oped a minimally perturbing method, which is 
not susceptible to any of the caveats of the classi-
cal mRNA half-life studies outlined above. Our 
method is based on the excision from the genome 
of a given loxP-flanked open reading frame, and 
hence discontinuance of transcription, following 
conditional nuclear targeting of the Cre recom-
binase. Using this assay, which we coin CEO (for 
conditional excision of the open reading frame 
[ORF]), we confirm our previous data, which 
indicated that inactivation of TORC1 results 
in stabilization of newly expressed mRNAs of 
Msn2-, Msn4-, and Gis1-controlled genes.5,17-19 
Using CEO, we extend our earlier studies and 
demonstrate that TORC1 controls mRNA sta-
bility via the Cdc55-protein phosphatase 2A 
(PP2ACdc55), which we recently found to be also 
implicated in direct regulation of the transcrip-
tion factor Gis1.18 Thus, our data indicate the 
existence of a mechanism that allows cells to 
tightly coordinate transcription with the post-
transcriptional fate of specific mRNAs under 
nutrient stress conditions.
Results
The experimental system. To design our 
method, we used a Cre recombinase that is fused to the estra-
diol-binding domain (EBD) of the murine estrogen receptor 
(Cre-EBD78),20,21 which mediates the cytoplasmic to nuclear 
translocation of the fusion protein following its association with 
estradiol. This construct can therefore be used to conditionally 
grant the Cre recombinase access to loxP sites in the genome.22 
Stable and constitutive expression (from the GPD1 promoter) of 
the Cre-EBD78 fusion protein was achieved by integration of 
the corresponding fusion gene at the ADE3 locus in the genome 
(Fig. 1; of note, expression of this fusion protein as such did not 
measurably alter the expression profile of HSP26 [or of RTN2 
or CIT2; see below] in exponentially growing and rapamycin-
treated wild-type cells; data not shown). In parallel, loxP sites 
were introduced just downstream of and in-frame with the ATG 
as well as downstream of the 3' untranslated region (UTR) of 
the HSP26 gene using the single-step PCR-based gene replace-
ment technique (Material and Methods; Fig. 1).23 Addition of 
treatment, can alter mRNA stability and, rather than blocking, 
in fact strongly induce transcription of heat-shock and/or stress-
responsive genes.8-12 In addition, since stress-responsive genes 
depend on their native promoters for normal induction under 
stress conditions, alternative methods that make use of condi-
tionally repressible promoters to downregulate transcription 
(such as the Tet
off
 system)7 cannot be applied to assess the half-
life of the respective mRNAs. Most recent mRNA half-life assays 
are based on metabolic labeling of newly transcribed mRNAs 
with 4-thiouracil (4-tU) or 4-thiouridine (4-sU), which requires 
the heterologous expression of a human nucleoside transporter 
(hENT1) to enable 4-sU uptake by yeast cells.13,14 Potential 
concerns regarding the applicability of 4-tU-pulse/uracil-chase 
experiments to assess the half-lives of newly expressed mRNAs 
under dynamic stress conditions, however, include the required 
long pulse/labeling period (i.e. > 4 h) and the possibility of 
uncontrolled 4-tU recycling within cells.15 Finally, dynamic 
Figure 1. Schematic representation of the relevant features of the various plasmids used 
in this study. The Ndei-Sphi 10.4-kb fragment from plasmid pNT081 can be integrated at 
the ADE3 locus via homologous recombination and mediates constitutive expression of 
cre-eBD78. Plasmids pNT082, pNT084, and pNT085 contain the HSP26, RTN2, and CIT2 
reporter constructs that, following excision from the plasmids with Xbai/Spei, Kpni or Naei/
Kpni as indicated, can be integrated at the respective endogenous loci via homologous 
recombination. The plasmid pNT083 serves as a backbone to facilitate construction of any 
reporter construct of choice. Please note that the loxP site codes for 12 additional amino 
acids and cloning of any ORF should be designed to be in-frame with the 5' and 3' ends 
of the indicated loxP-derived reading frame. For a more detailed description of plasmid 
constructions, please see the section Materials and Methods.
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high in this experiment. Using this method, we determined 
a half-life of 55 min for HSP26 mRNA in rapamycin treated 
(130 min) cells (Fig. 3A).
To demonstrate that CEO is more broadly applicable, we also 
studied two additional genes (i.e., RTN2 and CIT2) and their 
respective mRNAs, which we previously found to be strongly 
induced following rapamycin treatment.5 To this end, we con-
structed an additional hygromycin-selectable plasmid (pNT083) 
containing the two loxP sites and several restriction sites that 
facilitate construction of the DNA fragments that allow intro-
duction of the loxP-reporter genes by single-step gene replace-
ment in yeast (Materials and Methods; Fig. 1). Like the HSP26 
reporter gene described above, Cre-EBD78-excisable RTN2 and 
CIT2 reporter genes were efficiently (and with similar kinetics) 
removed from the genomes of the respective reporter strains fol-
lowing addition of estradiol, which on its own had no detect-
able effect on RTN2 or CIT2 expression (not shown). Using the 
same conditions as above for determination of the HSP26 mRNA 
half-life, we found that RTN2 and CIT2 mRNAs exhibited 
estradiol to yeast cells containing both reporter constructs 
should therefore trigger nuclear transfer of the Cre-EBD78 
fusion protein and consequent excision of the HSP26 ORF 
(including the HSP26 - 3'(a) region; Fig. 2A). To verify this 
assumption, exponentially growing wild-type cells harbor-
ing the two reporter constructs (referred to as “reporter cells/
strain” hereafter) were treated with rapamycin for 60 min 
to induce the expression of HSP26 (which was normal when 
compared with wild-type cells bearing no reporter constructs; 
Fig. 2B). The culture was then equally split and the two sub-
cultures were either treated with vehicle alone or with estradiol, 
which per se did not significantly alter the HSP26 expression 
levels in rapamycin-treated wild-type cells carrying no reporter 
genes (Fig. 2C). As expected, estradiol treatment, but not treat-
ment with the vehicle alone, triggered the excision of the ORF 
at the HSP26 locus in reporter cells (Fig. 2A). Notably, most of 
the HSP26 loci (i.e. > 96%) were excised within 20 min follow-
ing a 50 min lag period (Fig. 2A) and the remaining fraction of 
HSP26 loci contributed only marginally (i.e. < 3%) to the exist-
ing pool of HSP26 mRNAs (as assessed in separate experiments 
in which HSP26 mRNA expression was quantified during a 1 h 
rapamycin treatment in reporter cells that had been first exposed 
to estradiol for 70 min; data not shown). To determine the half-
life of HSP26 mRNAs, we have therefore started to collect sam-
ples (in 10 min intervals) 70 min following estradiol treatment, 
at which point in time HSP26 mRNA levels were maximally 
Figure 2. Description of the ceO method. (A) The cre-eBD78 fu-
sion protein (expressed under the control of the GPD1 promoter) is 
predominantly localized in the cytoplasm in the absence of estradiol, 
but shuttles into the nucleus following estradiol (1 μM) addition to 
reporter cells. Nuclear cre-eBD78 mediates recombination between 
loxP sites that are introduced (in tandem orientation) in the genome 
just downstream of and in-frame with the ATG as well as down-
stream of the 3' UTR of target genes using the single-step PcR-based 
gene replacement technique (and the hygromycin-resistance gene 
(hphNT1) as selectable marker). As a proof of principle, exponentially 
growing wild-type cells harboring the cre-eBD78 and loxP-HSP26-
loxP reporter constructs (NT393-6D) were treated with rapamycin 
(200 ng ml−1) to induce the expression of HSP26, followed by addition 
of estradiol (at time 60 min) to trigger excision of the HSP26 ORF and 
the hphNT1 cassette from the genome (as illustrated). The efficacy of 
HSP26 excision was assessed by qPcR using the indicated primers (P1 
and P2) and genomic DNA as template. Bar graphs show the mean 
levels of three independent experiments (± S.D.) of PcR-amplified 
HSP26 (normalized to 1.0 for exponentially growing, untreated cells) 
in cells treated with either vehicle alone (v; on the left) or with estra-
diol (on the right) for the times indicated. Samples to determine the 
half-life of HSP26 mRNA were collected (at 10 min intervals) 70 min 
following vehicle or estradiol treatment and the respective data are 
presented in Figure 3A. (B) qRT-PcR analysis of HSP26 mRNA induc-
tion in wild-type (WT) and loxP-HSP26-loxP reporter cells (same as in 
(A)) treated for the times indicated with 200 ng ml−1 rapamycin. Mean 
HSP26 mRNA levels of three independent experiments (± S.D.), nor-
malized to the values at 60 min, are shown. Notably, in terms of ab-
solute levels, the rapamycin-induced accumulation of HSP26 mRNA 
(and of hsp26 protein) did not significantly differ in loxP-HSP26-loxP 
reporter cells when compared with wild-type cells (data not shown). 
(C) estradiol per se (added at time 60 min), like vehicle alone, does 
not interfere with rapamycin-induced HSP26 expression (quantified 
by qRT-PcR as in [B]) in wild-type cells.
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process that depends on the greatwall protein kinase ortho-
log Rim15 and its targets Igo1/2.5 In this study, the experi-
mental caveats of mRNA half-life assays (outlined above) 
were circumvented by rendering HSP26 transcription dox-
ycycline-repressible due to the insertion of a series of dox-
ycycline-responsive tetO elements in the HSP26 promoter. 
Notably, identification of sites in the HSP26 promoter that 
tolerated the respective tetO insertions without interfer-
ing with normal transcriptional regulation of HSP26 was 
challenging and time-consuming. Using the much easier 
applicable CEO assay, we confirm here our earlier results 
that loss of Rim15 or of Igo1/2 reduced the HSP26 mRNA 
half-life in rapamycin-treated cells about 2-fold (Fig. 3A). 
To further extend these data, we also studied the half-lives 
of two additional mRNAs, which were encoded by genes 
that either depended (i.e., RTN2), or did not depend (i.e., 
CIT2), on the presence of Rim15 and Igo1/2 for normal 
expression following TORC1 inactivation.5 In line with 
our expectations, we found that the half-life of the RTN2 
mRNA, but not the one of CIT2 mRNA, was reduced 
2-fold in rapamycin treated rim15Δ and igo1Δ igo2Δ cells 
when compared with wild-type cells (Fig. 3B and C). 
These data not only demonstrate the validity of CEO for 
mRNA half-life studies, but also corroborate our earlier 
conclusion that TORC1 controls the stability of a specific 
set of mRNAs via Rim15-Igo1/2.5,17,24,25
TORC1 controls mRNA stability via the PP2ACdc55-
inhibitory endosulfines. We recently discovered that 
Rim15, analogous to the greatwall kinase in Xenopus, phos-
phorylates endosulfines (i.e. Igo1/2) to directly inhibit the 
Cdc55-protein phosphatase 2A (PP2ACdc55).18 Accordingly, 
when phosphorylated by Rim15 on Ser64, Igo1 directly 
binds to and prevents PP2ACdc55 from dephosphorylating 
various target proteins among which we identified the 
transcription factor Gis1. Inhibition of PP2ACdc55 preserves 
Gis1 in a phosphorylated state and consequently promotes 
its recruitment to and activation of transcription from pro-
moters of specific nutrient-regulated genes such as RTN2. 
Together with our earlier studies, these recent data suggest 
that Igo1/2, following their activation by Rim15, stimu-
late both transcriptional activation of Gis1-dependent 
genes and post-transcriptional stability of the respective 
mRNAs by inhibiting PP2ACdc55. To address this assump-
tion further, using the CEO method, we studied whether 
loss of Cdc55 may suppress the defect in HSP26 and RTN2 
mRNA stability that we observed in rapamycin-treated 
rim15Δ and igo1Δ igo2Δ cells (Fig. 3A and B). Mutant 
cdc55Δ cells exhibited slightly enhanced (i.e. 1.3–1.4-
fold) HSP26 and RTN2 mRNA half-lives when compared 
with wild-type cells treated with rapamycin (Fig. 3D and 
E). Interestingly, in contrast to the situation in wild-type 
cells, loss of Rim15 or of Igo1/2 had no significant impact on 
the observed HSP26 and RTN2 mRNA half-lives in cdc55Δ cells 
under the same conditions (Fig. 3D and E). Thus, the enhanced 
turnover of HSP26 and RTN2 mRNAs in rapamycin-treated 
rim15Δ and igo1/2Δ cells can be suppressed by loss of Cdc55. 
half-lives of 34 and 38 min, respectively, in rapamycin-treated 
cells (Fig. 3B and C).
Validation of CEO. We have previously reported that inac-
tivation of TORC1 results in stabilization of newly expressed 
mRNAs of Msn2-, Msn4- and Gis1-controlled genes via a 
Figure 3. TORc1 controls mRNA stability via the PP2Acdc55-inhibitory endosul-
fines. (A–E) qRT-PcR analysis of HSP26 (A and D), RTN2 (B and E) and CIT2 (C) 
mRNA levels in rapamycin-treated cells. mRNA samples were harvested from 
cells, which harbored the cre-eBD78 and an appropriate loxP-ORF-loxP reporter 
construct (see Table 1) and that were treated with rapamycin and estradiol fol-
lowing the protocol outlined in Figure 2A. The values for the reference samples 
at time point 0 (corresponding to the time point 130 min of the rapamycin 
treatment) were normalized to 1.0 for each strain. Notably, the Rim15-igo1/2-
PP2Acdc55 signaling branch also regulates transcription (in part via Gis1) of HSP26 
and RTN2, but not of CIT2 (see also the model in Fig. 4).5,18,31 Before their normal-
ization to 1.0, the relative levels of HSP26 and RTN2 mRNAs, but not the ones 
of CIT2, therefore differed significantly between the various mutant strains. 
Accordingly, the HSP26 mRNA levels in rim15Δ, igo1/2Δ, cdc55Δ, cdc55Δ rim15Δ, 
and cdc55Δ igo1/2Δ cells were 23%, 13%, 225%, 170%, and 196%, respectively, 
when compared with those in wild-type cells (in [A and D]). Similarly, RTN2 
mRNA levels in rim15Δ, igo1/2Δ, cdc55Δ, cdc55Δ rim15Δ, and cdc55Δ igo1/2Δ cells 
were 17%, 25%, 155%, 150% and 132%, respectively, when compared with those 
in wild-type cells (in [B and E]). estradiol-induced excision of the loxP-ORF-loxP 
loci was verified independently and found to be at least 85% complete for 
each strain at time point 0 (i.e. 70 min following estradiol addition). Data points 
represent means ± S.D. of three independent experiments.
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thereby favoring promoter recruitment of and transcription by 
the transcription factor Gis1.18 These new data raised the ques-
tion whether Igo1/2-mediated inhibition of PP2ACdc55 may, in 
addition to its role in transcription, also be implicated in post-
transcriptional control of mRNA stability. Our data presented 
here indicate that this is the case. Thus, Igo1/2-dependent reg-
ulation of PP2ACdc55 appears to represent a key node in nutri-
ent-sensitive, homo-directional coordination of transcription 
and post-transcriptional mRNA stabilization of a specific array 
of genes (Fig. 4). Interestingly, loss of components of the 5'-3' 
mRNA decay pathway, like loss of Cdc55, suppresses the defect 
in HSP26 expression in rapamycin-treated igo1/2Δ cells.5,17,18 It is 
therefore possible that PP2ACdc55 regulates, in addition to Gis1, 
a specific protein(s) within the 5'-3' mRNA decay pathway. In 
this context, our previously published phosphoproteome studies 
pinpointed, among others, Vts1 as a potential PP2ACdc55 target.18 
Vts1 is a member of the Smaug family of proteins, which directly 
binds a defined RNA motif in target mRNAs of nutrient-reg-
ulated genes and controls their stability by interfering with the 
5'-3' mRNA decay pathway.33,34 It will therefore be interesting 
to explore in future studies whether parallel, temporally coordi-
nated regulation by the Igo1/2-PP2ACdc55 module of both Gis1 
and Vts1 (or of other candidate proteins) may allow cells to coor-
dinate transcription and posttranscriptional mRNA stability.
Materials and Methods
Strains and growth conditions. S. cerevisiae strains (Table 1) were 
grown at 30°C in standard rich medium (YPD) with 2% glucose 
or in synthetic defined (SD) medium (0.17% yeast nitrogen base, 
0.5% ammonium sulfate, and 2% glucose) complemented with 
These data extend our previous model and suggest that TORC1 
controls in fact both transcriptional activation of Gis1-dependent 
genes and post-transcriptional stability of the respective mRNAs 
via the Rim15-Igo1/2-PP2ACdc55 effector branch (Fig. 4).
Discussion
Here we describe an alternative method to study the mRNA half-
life of stress-responsive genes in yeast that is based on the condi-
tional excision of ORFs (CEO). CEO offers a distinct advantage 
over conventional mRNA half-life assays that build on the inac-
tivation of transcription using either the temperature-sensitive 
rpb1-1 allele or a variety of specific transcription inhibitors (see 
Introduction). Accordingly, CEO relies on estradiol treatment 
(to induce cytoplasmic to nuclear transfer of the Cre-EBD78 
fusion protein), which, unlike heat-shock (when using rpb1-1 
mutants) or various treatments with transcription inhibitory 
drugs, per se does neither induce the expression nor interfere with 
the normal (rapamycin-mediated) regulation of stress-responsive 
genes such as HSP26, RTN2, and CIT2 (Fig. 2C and data not 
shown). Based on our observation that estradiol-induced exci-
sion of various target ORFs was exerted to a large extent within 
a time frame of 10–20 min (following a lag period of 50 min), 
we infer that CEO represents a valid method to determine the 
stability of those mRNA species that exhibit half-lives of at least 
10–20 min. An additional advantage of CEO is that it preserves 
the endogenous structures of the 5'/3' UTRs and the promoters 
of the genes under study, which makes CEO less likely to alter the 
fate of mRNAs than traditional methods that are based on the 
use heterologous repressible promoters.26-30 Although it remains 
theoretically possible that the insertion of a loxP site within the 
ORF of a given target gene may affect its expression, our control 
experiments, in which we compared the level of HSP26 mRNAs 
between rapamycin-treated wild-type and loxP-HSP26-loxP cells, 
indicated that the introduction of a loxP site within the HSP26 
ORF per se is minimally invasive with no significant effect on the 
expression and/or stability of HSP26 mRNAs. Taken together, 
despite a few limitations (regarding the resolution of half-lives 
of very short-lived mRNAs and the unsuitability for genome-
wide analyses), CEO offers a valid alternative to sample the 
mRNA half-life of stress-responsive genes, which, together with 
the toolbox offered here, only requires relatively easily applicable 
standard yeast genetic methods. Finally, although not specifi-
cally studied here, we would like to point out that CEO may in 
principle also be applied to the analysis of gene function as it 
allows conditional inactivation of specific genes. Provided that 
the respective gene products have a relatively limited half-life, 
CEO could be particularly useful to replace and/or complement 
analyses of essential genes that have hitherto relied on the use of 
temperature-sensitive alleles.
The use of CEO allowed us to confirm our previous finding 
that the protein kinase Rim15, which is indirectly and nega-
tively controlled by TORC1,24,25,31,32 plays a key role in stabiliz-
ing mRNAs of Msn2/4- and Gis1-controlled genes via its direct 
targets Igo1/2. More recently, we discovered that, following their 
phosphorylation by Rim15, Igo1/2 serve to inhibit PP2ACdc55, 
Figure 4. Model for the role of igo1/2-PP2Acdc55 in controlling expres-
sion of nutrient-regulated genes. Arrows and bars denote positive and 
negative interactions, respectively. TORc1 regulates Rim15 indirectly via 
Sch9.25 For details, see text.
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control of the TEF1 promoter. pNT083 is based on pRS316 and 
was designed to facilitate construction of reporter cassettes for 
use in CEO assays. To this end, a fragment containing the 300 
bp upstream of and including the ATG plus the first 15 bp of the 
ORF of a given gene can be cloned at the NaeI and NotI sites (or 
only at NotI) in pNT083 (in-frame with the subsequent loxP-
encoded sequence indicated in Fig. 1). A second fragment coding 
for the entire ORF (except the ATG) plus at least 300 bp down-
stream of and including the stop codon can be cloned at the XbaI 
and BamHI sites (or only at XbaI; in frame with the preceding 
loxP-encoded sequence). Finally, a third fragment including at 
least the first 300 bp of the 3' region following the stop codon can 
be cloned at the SalI and/or KpnI sites. For homologous recom-
bination in yeast, the entire cassette can then be removed from 
the plasmid by digestion with NaeI and KpnI. Both plasmids 
pNT084 and pNT085 were constructed using this approach and 
pNT083 as template. Accordingly, pNT084 contains sequen-
tially the 300 bp upstream of and including the ATG plus the 
first 18 bp of RTN2 (RTN2-5' ), a first loxP site that preserves 
the reading frame with respect to the preceding ATG and the 
following RTN2 ORF (encoding amino acids 4–393), the 295 
bp downstream of and including the RTN2 stop codon (RTN2-
3'), the hphNT1 cassette, a second loxP site (in tandem orienta-
tion with the first loxP site), and the 295 bp downstream of the 
RTN2 stop codon (RTN2-3'). Digestion of pNT084 with KpnI 
generates two fragments (3882 and 4482 bp) of which the 3882 
bp fragment can be inserted at the RTN2 locus by homologous 
the appropriate nutrients for plasmid maintenance. Rapamycin 
and estradiol were used at a concentration of 200 ng ml−1 and 
1 μM, respectively.
Plasmid constructions. The plasmids used in this study are 
depicted in Figure 1. pNT081, containing part of the ADE3 gene 
(i.e. 600 bp upstream and 400 bp downstream of the ATG), is 
derived from pGPD1:Cre-EBD78.20,21 Digestion of pNT081 with 
NdeI and SphI generates a 10.4 kb fragment that drives integration 
of the GPD1:Cre-EBD78 cassette into the genomic ADE3 locus 
in yeast. Positive clones can be selected using the LEU2 marker 
that is also present on this fragment. pNT082 was constructed by 
inserting, via homologous recombination, elements of the HSP26 
gene into the pFA6a-CEN4-ASK1-loxP-HphNT1 plasmid (kind 
gift of Yves Barral). Digestion of pNT082 with XbaI and SpeI 
generates two fragments (3686 and 3240 bp) of which the 3686 
bp fragment can be inserted at the HSP26 locus by homologous 
recombination. As illustrated in Figure 1, this fragment contains 
sequentially the 347 bp upstream of and including the ATG plus 
the first 18 bp of the HSP26 ORF (HSP26-5' ), a first loxP site 
that preserves the reading frame with respect to the preceding 
ATG and the following HSP26 ORF (encoding amino acids 
2–214), the 428 bp downstream of and including the stop codon 
of HSP26 (HSP26 - 3' [a]), the hphNT1 cassette, a second loxP 
site (in tandem orientation with the first loxP site) and the last 
42 bp of the HSP26 ORF, including the stop codon followed by 
343 bp of the 3' region (HSP26 - 3' [b]). The hphNT1 cassette 
allows expression of the hygromycin B resistance gene under the 
Table 1. Strains used in this study
Strain Genotype Source Figure
BY4741 MATa; ura3Δ0, leu2Δ0, his3Δ1, met15Δ0 euroscarf 2B, c
BY4742 MATα; ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0 euroscarf
NT393–1D MATa; HSP26-5’-loxP-HSP26-HphNT1-loxP-HSP26-3' [BY4741/2] this study 2B
NT393–6D MATa; HSP26-5'-loxP-HSP26-HphNT1-loxP-HSP26-3', ADE3::GPD1:Cre-EBD78-LEU2 [BY4741/2] this study 2A, 3A
NT394–1c MATa; rim15Δ::kanMX, HSP26-5'-loxP-HSP26-HphNT1-loxP-HSP26-3', ADE3::GPD1:Cre-EBD78-LEU2 [BY4741/2] this study 3A
NT395–8A MATα; igo1Δ::kanMX, igo2Δ::kanMX, HSP26-5'-loxP-HSP26-HphNT1-loxP-HSP26-3', ADE3::GPD1:Cre-EBD78-LEU2 
[BY4741/2]
this study 3A
NT401–10c MATa; cdc55Δ::kanMX, HSP26–5'-loxP-HSP26-HphNT1-loxP-HSP26–3', ADE3::GPD1:Cre-EBD78-LEU2 [BY4741/2] this study 3D
NT402–13c MATa; cdc55Δ::kanMX, rim15Δ::kanMX, HSP26–5'-loxP-HSP26-HphNT1-loxP-HSP26–3', ADE3::GPD1:Cre-EBD78-LEU2 
[BY4741/2]
this study 3D
NT404–14D MATα; cdc55Δ::kanMX, igo1Δ::kanMX, igo2Δ::kanMX, HSP26-5'-loxP-HSP26-HphNT1-loxP-HSP26–3', ADE3::GPD1:Cre-
EBD78-LEU2 [BY4741/2]
this study 3D
NT418–10B MATα; RTN2-5'-loxP-RTN2-HphNT1-loxP-RTN2-3', ADE3::GPD1:Cre-EBD78-LEU2 [BY4741/2] this study 3B
NT417–2B MATα; rim15Δ::kanMX, RTN2–5'-loxP-RTN2-HphNT1-loxP-RTN2-3', ADE3::GPD1:Cre-EBD78-LEU2 [BY4741/2] this study 3B
NT416–17c MATα; igo1Δ::kanMX, igo2Δ::kanMX, RTN2–5'-loxP-RTN2-HphNT1-loxP-RTN2–3', ADE3::GPD1:Cre-EBD78-LEU2 
[BY4741/2]
this study 3B
NT417–4c MATα; cdc55Δ::kanMX, RTN2-5'-loxP-RTN2-HphNT1-loxP-RTN2-3', ADE3::GPD1:Cre-EBD78-LEU2 [BY4741/2] this study 3e
NT417–17c MATα; cdc55Δ::kanMX, rim15Δ::kanMX, RTN2-5'-loxP-RTN2-HphNT1-loxP-RTN2-3', ADE3::GPD1:Cre-EBD78-LEU2 
[BY4741/2]
this study 3e
NT425–3D MATα; cdc55Δ::kanMX, igo1Δ::kanMX, igo2Δ::kanMX, RTN2–5'-loxP-RTN2-HphNT1-loxP-RTN2–3', ADE3::GPD1:Cre-
EBD78-LEU2 [BY4741/2]
this study 3e
NT422–1c MATa; CIT2-5'-loxP-CIT2-HphNT1-loxP-CIT2-3', ADE3::GPD1:Cre-EBD78-LEU2 [BY4741/2] this study 3c
NT424–17D MATa; rim15Δ::kanMX, CIT2-5'-loxP-CIT2-HphNT1-loxP-CIT2-3', ADE3::GPD1:Cre-EBD78-LEU2 [BY4741/2] this study 3c
NT423–1B MATa; igo1Δ::kanMX, igo2Δ::kanMX, CIT2-5'-loxP-CIT2-HphNT1-loxP-CIT2-3', ADE3::GPD1:Cre-EBD78-LEU2 [BY4741/2] this study 3c
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AAGGCCGTCT CTTCCTCTTC (NSR1qF2); 
GGTTTCAGC TTCACTTTCG C (NSR1qR2); 
TGTTTTTAAT CCATTCACCT TTCAT (HSP26 
gF2; P1); CCTTCACCCA GCAATCTGTT (HSP26 
gR2; P2); AGTTAGCAAA CACACCCGCA AAGG 
(HSP26qF1); TGCTCTCCTT GACCTTGACC 
(HSP26qR1); TCTGGTGAGT TTGCTGATCC 
(RTN2qF1); GCGGTCGATA TGAGGCTTTA AG 
(RTN2qR1); ATCACCTTAT CTGTCCCTTG C 
(CIT2qF1); ACAGCATGAC CATAACCGG (CIT2qR1).
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recombination. Similarly, the pNT085 contains sequentially the 
295 bp upstream of and including the ATG plus the first 18 bp of 
CIT2 (CIT2-5' ), a first loxP site that preserves the reading frame 
with respect to the preceding ATG and the following CIT2 ORF 
(encoding amino acids 2–460), the 300 bp downstream of and 
including the CIT2 stop codon (CIT2-3' ), the hphNT1 cassette, 
a second loxP site (in tandem orientation with the first loxP site) 
and the 300 bp downstream of the CIT2 stop codon (CIT2-3' ). 
Digestion of pNT085 with NaeI and KpnI generates two frag-
ments (4121 and 4460 bp) of which the 4121 bp fragment can be 
inserted at the CIT2 locus by homologous recombination.
Real-time qPCR and qRT-PCR. High-quality yeast genomic 
DNA preparation was mainly performed as described previously 
with minor modifications.35 At each step, one-tenth of the indi-
cated values was used. Total RNA was extracted using the hot 
acidic phenol method. DNA was removed with the DNA-free 
Kit (Ambion) and first-strand cDNA was synthesized with the 
PrimeScript RT Reagent Kit (TaKaRa). Quantitative RT-PCR 
(qRT-PCR) was performed on a Rotor-Gene 6000 machine 
(Corbett Life Science), with the 5 x EvaGreen QPCR Mix II 
no Rox (Bio&SELL) or with the QuantiTect SYBR Green PCR 
Kit (Qiagen). HSP26, RTN2 and CIT2 DNA and mRNA lev-
els were normalized with respect to NSR1 DNA or mRNA. 
Oligonucleotides used for qPCR and qRT-PCR were as follows: 
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